Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.
Fusion Antibodies: results underwhelm
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Advanced Medical Solutions
Gold winner | Entrepreneurial success | CEO suspension
There are plenty of excellent results from AIM covered here, but we are surprised a pawnbroker…
Medical advances | Stonking Small Cap update | Measured growth
News covered here includes our assessment of excellent results from a diversified financial services provider and…
More on Argentex Group PLC
Bonkers Bargains: returning to growth
A new management team is executing its plan to accelerate growth in this expert in currency risk management…
Episode 4 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…
More on Frasers Group
10% dividend yield | Another brand buy | Frasers falls
News covered here incudes our assessment of results from a lowly valued UK fund manager, whose…
AIM takeovers | Automotive excellence and struggles
One of AIM’s largest companies seems inclined to accept a private equity funded offer, with an…
More on Fusion Antibodies PLC
Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
Coronavirus impact: 28 April - soaring share prices from this little lot
Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…
